In silico docking and Molecular Dynamic (MD) simulations studies of selected phytochemicals against Human Glycolate Oxidase (hGOX) and Oxalate oxidase (OxO)

Abstract

Globally, Urolithiasis is the most prevalent urological problem which affects the populations across the ages and races. In recent years, several phytochemicals are being investigated to improve the efficacy and safety of anti-urolithiasis formulations. To develop drugs based on traditional medicines, it is essential to understand the molecular mechanism of action of these drugs. We present the results of in silico docking and molecular dynamic (MD) simulation studies on selected phytochemical including catechin, epicatechin, gallic acid, gallocatechin, epigallocatechin, epigallocatechin 3-o-gallate, 4-methoxy-nor-securine, nor-securinine, and fisetin with human glycolate oxidase (hGOX) and oxalate oxidase (OxO). Gallic acid, gallocatechin and fisetin showed better docking scores than the rest. In MD simulation analysis, stable interactions of the gallic acid with hGOX and OxO; gallocatechin and fisetin with hGOX were observed. It was found that, gallic acid stably interacts withTYR26, LYS 236, ARG 315, and ASP 291 residues of hGOX. On other hand, gallic acid stably interacs with GLU 58 residue of OxO. Gallocatechin, forms stable interactions with TYR 26, ASP 170, ARG 167 and THR 161 of HGOX. In MD simulations, fisetin stably interacted with TYR 26, TRP110 and ARG 263 as we predicted in molecular docking. None of the interactions was formed during the MD simulation of OxO with gallocatechin and fisetin. Together, these results suggest that gallic acid, gallocatechin and fisetin are the potential candidates for the development of phytochemicals for the management of urolithiasis in humans.

Key words

urolithiasis - molecular docking simulations - fisetin - gallic acid - oxalate oxidase - glycolate oxidase

Publication History

Received: 10 March 2023

Accepted: 02 May 2023

Article published online:
24 July 2023

• References

• 1 Thakore P, Liang TH.. Urolithiasis. [Updated 2022 Jun 11]. In: StatPearls (ed). Treasure Island (FL): StatPearls; 2022: NBK559101
• 2 Pearle MS, Calhoun EA, Curhan GC.. Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol 2005; 173: 848-57
• 3 Qian X, Wan J, Xu J. et al. Epidemiological trends of urolithiasis at the global, regional, and national levels: a population-based study. Int J Clin Pract 2022; 2022
• 4 Al-Mamari SA.. Etiology of urolithiasis. In: Said Abdallah AM (ed). Urolithiasis in Clinical Practice. Switzerland: Springer; 2017: 57-111
• 5 Bawari S, Sah AN, Tewari D.. Urolithiasis: An update on diagnostic modalities and treatment protocols. IJPS 2017; 79: 164-74.
• 6 Knoll T.. Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Europ. Urol 2010; 9: 802-6
• 7 Ogawa Y, Miyazato T, Hatano T.. Oxalate and urinary stones. World J Surg 2000; 24: 1154-9
• 8 Murray MS, Holmes RP, Lowther WT.. Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design. Biochemistry 2008; 47: 2439-49
• 9 Opaleye O, Rose RS, Whittaker MM. et al. Structural and spectroscopic studies shed light on the mechanism of oxalate oxidase. J Biol Chem 2006; 281: 6428-33
• 10 Kumari CS, Logeshwari B.. In silico and in vitroevaluation of anti-urolithiatic activity of ethanolic extract of Hybanthus Enneaspermus (Linn.) F. Muell. IJPRA 2021; 6: 548-560
• 11 Carlesso A, Chintha C, Gorman AM. et al. Merits and pitfalls of conventional and covalent docking in identifying new hydroxyl aryl aldehyde like compounds as human IRE1 inhibitors. Scientific reports 2019; 9: 3407
• 12 Bernatoniene J, Kopustinskiene DM.. The role of catechins in cellular responses to oxidative stress. Molecules 2018; 23: 965
• 13 Hess B, Kutzner C, Van Der Spoel D. et al. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008; 4: 435-47
• 14 Vijayakumar S, Manogar P, Prabhu S. et al. Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease. J Pharm Anal 2018; 8: 413-20.
• 15 Modi P, Patel S, Chhabria M.. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo [1, 5-a] pyrimidine analogues as potential anti-tubercular agents. Bioorg Chem 2019; 87: 240-51.
• 16 Pradeep H, Rajanikant GK.. A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3β. Mol Divers 2012; 16: 553-62
• 17 Jasuja H, Chadha N, Kaur M. et al. Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore-and docking-based virtual screening approach. Mol Divers 2014; 18: 253-67
• 18 Huang H, Zhang G, Zhou Y. et al. Reverse screening methods to search for the protein targets of chemopreventive compounds. Front Chem 2018; 138
• 19 Berendsen HJ, Postma JP, van Gunsteren WF. et al. Interaction Models for Water in Relation to Protein Hydration. In: Pullman B.(ed). Intermolecular Forces. Dordrecht: Springer; 1981: 331-342
• 20 Bourhis JM, Vignaud C, Pietrancosta N. et al. Structure of human glycolate oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl) sulfanyl]-1, 2, 3-thiadiazole. Acta Crystallogr Sect F Struct Biol Cryst Commun 2009; 65: 1246-53
• 21 Boehr DD, Farley AR, Wright GD. et al. Analysis of the π-π stacking interactions between the aminoglycoside antibiotic kinase APH (3′)-IIIa and its nucleotide ligands. Chem Biol 2002; 9: 1209-17
• 22 Deng JH, Luo J, Mao YL. et al. π-π stacking interactions: Non-negligible forces for stabilizing porous supramolecular frameworks. Sci Adv 2020; 6: eaax9976
• 23 Kaushik S, Choudhary M, Rajpal S.. Antiurolithiatic efficacy of combination preparations of Dolichos biflorus and Crataeva nurvala: folk medicines used in Indian traditional medicine. FJPS 2021; 7: 1-7
• 24 Mikawlrawng K, Kumar S, Vandana R.. Current scenario of urolithiasis and the use of medicinal plants as antiurolithiatic agents in Manipur (North East India): a review. Int. J. Herb. Med. 2014; 2: 1-2